Study to Image the Esophagus Using the OFDI Capsule
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02204150|
Recruitment Status : Completed
First Posted : July 30, 2014
Results First Posted : April 23, 2019
Last Update Posted : April 30, 2019
|Condition or disease||Intervention/treatment||Phase|
|Barrett's Esophagus Eosinophilic Esophagitis||Device: OFDI Capsule||Not Applicable|
A total of 56 subjects with Barrett's Esophagus, EoE and healthy volunteers will be asked to swallow the OFDI capsule while being unsedated. The capsule is attached to a tether that allows the capsule operator to navigate the capsule as it progresses down the esophagus using natural propulsion called peristalsis as well as to bring it back up to pulled out of the mouth when the procedure is done.
As the capsule progresses down the esophagus, multiple, two dimensional, microscopic cross- sectional images of the esophagus are acquired.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||56 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pilot Study for Imaging of the Esophagus Using an OFDI Capsule|
|Actual Study Start Date :||February 2012|
|Actual Primary Completion Date :||July 31, 2015|
|Actual Study Completion Date :||July 2016|
Experimental: OFDI Capsule Imaging
Subject will swallow the OFDI capsule and imaging will be acquired using the OFDI Imaging system.
Device: OFDI Capsule
Imaging of the esophagus using the OFDI Capsule and system
- Feasibility of OFDI Imaging in Subjects Swallowing the OFDI Capsule [ Time Frame: Images will be acquired during the OFDI imaging session which should take an average of 5 minutes ]Number of subjects from whom the quality OFDI imaging was obtained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02204150
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Guillermo Tearney, MD., PhD||Massachusetts General Hospital|